197 related articles for article (PubMed ID: 7047174)
1. Human natural killer-like activity against mouse spleen cells.
Yamamoto JK; Blalock JE; Johnson HM
Eur J Immunol; 1982 Mar; 12(3):222-7. PubMed ID: 7047174
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the primary in vitro antibody response by interferon preparations.
Johnson HM; Smith BG; Baron S
J Immunol; 1975 Jan; 114(1 Pt 2):403-9. PubMed ID: 1090660
[TBL] [Abstract][Full Text] [Related]
3. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the secondary in vitro antibody response by endogenous natural killer cells: kinetics, isotype preference, and non-identity with T suppressor cells.
Robles CP; Pollack SB
J Immunol; 1986 Oct; 137(8):2418-24. PubMed ID: 2944955
[TBL] [Abstract][Full Text] [Related]
7. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells.
Nunn ME; Herberman RB
J Natl Cancer Inst; 1979 Apr; 62(4):765-71. PubMed ID: 285291
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
Ghayur T; Seemayer TA; Lapp WS
Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
Rolstad B; Fossum S
Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
[TBL] [Abstract][Full Text] [Related]
11. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
Suzuki S; Suzuki R; Onta T; Kumagai K
Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
15. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
16. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
17. The effect of staphylococcal enterotoxins on the primary in vitro immune response.
Smith BG; Johnson HM
J Immunol; 1975 Aug; 115(2):575-8. PubMed ID: 1097520
[TBL] [Abstract][Full Text] [Related]
18. Triggering of human peripheral blood B cells: polyclonal induction and modulation of an in vitro PFC response.
Friedman SM; Breard JM; Chess L
J Immunol; 1976 Nov; 117(5 Pt.2):2021-8. PubMed ID: 792335
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
20. Asialo-GM1+ natural killer cells directly suppress antibody-producing B cells.
Robles CP; Pollack SB
Nat Immun Cell Growth Regul; 1989; 8(4):209-22. PubMed ID: 2797013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
